Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2007 1
2008 4
2009 3
2010 1
2011 2
2012 2
2013 2
2014 3
2015 1
2017 1
2018 2
2019 5
2020 10
2021 2
2022 9
2023 13
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
Acinar cystic transformation in the pancreatic tail.
Tatsumi M, Anazawa T, Masano Y, Yoh T, Nishino H, Yamane K, Nagai K, Uchida Y, Yoshizawa A, Hatano E. Tatsumi M, et al. Among authors: nagai k. Clin J Gastroenterol. 2023 Dec;16(6):919-924. doi: 10.1007/s12328-023-01838-2. Epub 2023 Jul 31. Clin J Gastroenterol. 2023. PMID: 37523124
Insights from managing clinical issues in distal pancreatectomy with en bloc coeliac axis resection: experiences from 626 patients.
Nakamura T, Okada KI, Ohtsuka M, Higuchi R, Takahashi H, Nagai K, Unno M, Murakami Y, Oba A, Tomikawa M, Kato A, Horiguchi A, Nakamura M, Yagi S, Satoi S, Endo I, Amano R, Matsumoto I, Ito YM, Nagakawa T, Hirano S. Nakamura T, et al. Among authors: nagai k. Br J Surg. 2023 Sep 6;110(10):1387-1394. doi: 10.1093/bjs/znad212. Br J Surg. 2023. PMID: 37469172
Safety and efficacy of neoadjuvant chemoradiotherapy with moderately hypofractionated intensity-modulated radiotherapy for resectable pancreatic cancer: A prospective, open-label, phase II study.
Masui T, Nagai K, Anazawa T, Kasai Y, Yogo A, Yoshimura M, Mizowaki T, Uza N, Fukuda A, Matsumoto S, Kanai M, Isoda H, Kawaguchi Y, Uemoto S, Hatano E. Masui T, et al. Among authors: nagai k. Cancer Med. 2023 Sep;12(18):18611-18621. doi: 10.1002/cam4.6470. Epub 2023 Aug 30. Cancer Med. 2023. PMID: 37649318 Free PMC article.
18F-labeled PEGylated exendin-4 imaging noninvasively differentiates insulinoma from an accessory spleen: the first case report of [18F]FB(ePEG12)12-exendin-4 positron emission tomography/computed tomography for insulinoma.
Sakaki K, Murakami T, Fujimoto H, Shimizu Y, Miyake KK, Otani D, Kiyobayashi S, Okada T, Fujimoto M, Hakata T, Yamauchi I, Shimada K, Shimizu H, Nagai K, Nakamoto Y, Inagaki N. Sakaki K, et al. Among authors: nagai k. Front Endocrinol (Lausanne). 2023 Aug 31;14:1245573. doi: 10.3389/fendo.2023.1245573. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37720533 Free PMC article.
Preoperative risk stratification of lymph node metastasis for non-functional pancreatic neuroendocrine neoplasm: An international dual-institutional study.
Kasai Y, Masui T, Nakakura EK, Nakano K, Sato A, Uchida Y, Yogo A, Nagai K, Anazawa T, Hope TA, Kim GE, Whitman J, Le BK, Takaori K, Bergsland EK, Hatano E, Uemoto S. Kasai Y, et al. Among authors: nagai k. Pancreatology. 2022 Jan;22(1):123-129. doi: 10.1016/j.pan.2021.10.005. Epub 2021 Oct 28. Pancreatology. 2022. PMID: 34736838 Free article.
57 results